CHD1Li 6.11 is a potent oncogenic CHD1L inhibitor (IC50=3.3 µM for cat-CHD1L recombinant protein). CHD1Li 6.11 is an orally bioavailable antitumor agent, significantly reducing the tumor volume of CRC xenografts generated from isolated quasi mesenchymal
Molecular Weight:
472.4
Purity:
98.5
CAS Number:
[2716890-91-2]
Formula:
C21H22BrN5OS
Target:
Others
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted